Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oger

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Annals of the New York Academy of Sciences|June 21, 1993
Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravisJ J Oger
Autoimmunity|January 1, 1995
HTLV-I associated myelopathy: a case of viral-induced auto-immunityJ Oger, G Dekaban
Pathology and Immunopathology Research|January 1, 1987
Cell-mediated immune functions in multiple sclerosisM O'Gorman, J Oger
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1992
Treatment of acquired autoimmune myasthenia gravis: a topic reviewP Verma, J Oger
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 28, 1999
Consensus statement of the Canadian MS CLinics Network on: the use of disease modifying agents in multiple sclerosisJ Oger, M Freedman
Annals of Neurology|January 1, 1994
Demyelination and ethnicity: experience at the University of British Columbia Multiple Sclerosis Clinic with special reference to HTLV-I-associated myelopathy in British Columbian nativesJ Oger, H Lai
Journal of Neuroimmunology|June 1, 1989
Search for nicotinic acetylcholine receptors on human leukocytes: absence of alpha-bungarotoxin binding in studies of healthy individuals and myasthenia gravis patientsR L Kaufman, J Oger
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspectiveH L Tremlett, J Oger
Neurology|May 1, 1988
Antibody production by blood lymphocytes in myasthenia gravis: reduction in disease of long durationR L Kaufman, J Oger
Cellular Immunology|February 1, 1989
Regulation of in vitro PWM-induced IgG secretion in humansM R O'Gorman, J J Oger
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|June 21, 1993
Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravisJ J Oger
Autoimmunity|January 1, 1995
HTLV-I associated myelopathy: a case of viral-induced auto-immunityJ Oger, G Dekaban
Pathology and Immunopathology Research|January 1, 1987
Cell-mediated immune functions in multiple sclerosisM O'Gorman, J Oger
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1992
Treatment of acquired autoimmune myasthenia gravis: a topic reviewP Verma, J Oger
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 28, 1999
Consensus statement of the Canadian MS CLinics Network on: the use of disease modifying agents in multiple sclerosisJ Oger, M Freedman
Annals of Neurology|January 1, 1994
Demyelination and ethnicity: experience at the University of British Columbia Multiple Sclerosis Clinic with special reference to HTLV-I-associated myelopathy in British Columbian nativesJ Oger, H Lai
Journal of Neuroimmunology|June 1, 1989
Search for nicotinic acetylcholine receptors on human leukocytes: absence of alpha-bungarotoxin binding in studies of healthy individuals and myasthenia gravis patientsR L Kaufman, J Oger
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspectiveH L Tremlett, J Oger
Neurology|May 1, 1988
Antibody production by blood lymphocytes in myasthenia gravis: reduction in disease of long durationR L Kaufman, J Oger
Cellular Immunology|February 1, 1989
Regulation of in vitro PWM-induced IgG secretion in humansM R O'Gorman, J J Oger
Pageof 13